Pillar [5] aromatics artificial transmembrane channel with antibacterial activity, preparation method and application thereof
A technology of antibacterial activity and transmembrane channel, which is applied in the field of artificial transmembrane channel of column [5] aromatics and its preparation, can solve the problems of difficult to eliminate hemolytic toxicity, low antibacterial activity, low hemolytic toxicity, etc., and achieve inhibition of bacterial growth , excellent antibacterial properties, the effect of changing permeability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] (1) Column [4] Preparation of aromatic hydrocarbon [1] quinone
[0023]
[0024] Dissolve column [5] aromatic hydrocarbon (3g, 4mmol) in dichloromethane (50mL), add ceric ammonium nitrate (2.19g, 4mmol), stir at room temperature for 30min, add water for extraction, and then use anhydrous Na 2 SO 4 Dry, filter, and spin-dry the filtrate. After column chromatography (ethyl acetate: petroleum ether), 1.44 g of solid was obtained, and the yield was 50%.
[0025] 1 H NMR (DMSO-d6, 600MHz) δ: 8.22 (s, 2H), 6.84 (s, 2H), 6.83 (s, 2H), 6.79 (s, 2H), 6.78 (s, 2H), 6.54 (s, 2H), 3.71(s, 6H), 3.68(s, 6H), 3.65(s, 12H), 3.63(s, 6H), 3.55(s, 4H).HRMS: Calcd for C 43 H 44 NaO 10 [M+Na] + :743.2832.Found:743.2867.
[0026] (2) Preparation of dihydroxy column [5] arene
[0027]
[0028] Column [4] arene [1] quinone (0.5 g, 0.693 mmol) and sodium borohydride (0.13 g, 3.448 mmol) were dissolved in tetrahydrofuran and stirred at room temperature. After the reaction is complete, extract with eth...
Embodiment 2
[0035] Preparation of column [5] arene modified with double octapeptide side chain
[0036]
[0037] Dissolve the azide-modified octapeptide (48mg, 0.05mmol, 3equiv) in DMSO (3mL), add diynyl column [5] arene (13mg, 0.016mmol), add sodium ascorbate (1.5mg, 0.008mmol, 0.5 equiv) and CuSO 4 ·5H 2 O (0.4mg, 1.6μmol, 0.1equiv). After stirring for 12h, spin dry. The obtained crude product was separated and purified by HPLC, and finally 30 mg of white solid was obtained with a yield of 67%.
[0038] 1H NMR (DMSO-d6, 600MHz) δ: 12.55 (s, 2H), 10.76 (s, 4H), 8.87-7.96 (m, 20H), 7.61 (t, J = 6.0Hz, 4H), 7.30 (t, J=6.0Hz,4H),7.13-6.92(m,14H),6.78(d,J=6.0Hz,4H), 6.75(d,J=6.0Hz,4H), 5.29-4.97(m,9H), 4.55-3.79(m,22H),3.51(d,J=6.0Hz,8H),3.20-2.87(m,11H),2.02-1.97(m,3H),1.47-1.44(m,5H),1.24- 1.06(m,27H),0.88(m,12H),0.69-0.59(m,25H).ESI-HRMS for C 145 H 180 N 26 O 30 [M+2H] 2+ calcd:1384.1769,found:1384.1838.
Embodiment 3
[0040] Preparation of column [5] arene modified with dipeptide side chain
[0041]
[0042] Dissolve the azide-modified decapeptide (64mg, 0.05mmol, 3equiv) in DMSO (3mL), add diynyl column [5] arene (13mg, 0.016mmol), add sodium ascorbate (1.5mg, 0.008mmol, 0.5 equiv) and CuSO 4 ·5H 2 O (0.4mg, 1.6μmol, 0.1equiv). After stirring for 12h, spin dry. The obtained crude product was separated and purified by HPLC, and finally 32 mg of white solid was obtained with a yield of 59%.
[0043] 1 H NMR(DMSO-d6,600MHz) δ: 10.76(s, 2H), 10.72(s, 2H), 10.71(s, 2H), 8.48(d, 2H), 8.38(t, 2H), 8.34-8.31( m, 4H), 8.18(s, 2H), 8.15(d, 4H), 8.04(d, 2H), 7.99(d, 2H), 7.92(d, 2H), 7.83(d, 2H), 7.59(q ,6H),7.30-7.27(m,6H),7.12(s,2H),7.08(s,4H),7.02-6.99(m,8H),6.96-6.91(m,6H),6.78(d,4H) ), 6.75 (d, 4H), 5.32 (t, 2H), 5.28-5.19 (m, 4H), 5.02-4.96 (m, 4H), 4.60-4.52 (m, 6H), 4.40-4.35 (m, 2H) ),4.25-4.15(m,8H),3.80(d,4H),3.66-3.65(m,24H),3.51(d,6H),3.21-3.18(m,4H),3.09-3.07(m,4H) ), 2.93-2.86(m, 6H),...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com